FDA NDC Directory · JSON-LD · Markdown

Cisatracurium Besylate

NDC 71288-714 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerMeitheal Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211669
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsCISATRACURIUM BESYLATE (20 mg/10mL)
Marketing started20191031
Package count1

External sources

Source: openFDA. Public-domain (CC0).